Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-21 | New | $25,000,141 | $25,000,141 | Equity Only | 06b | SEC link |
| 2025-05-21 | New | $29,929,943 | $29,929,943 | Equity Only | 06b | SEC link |
| 2025-05-21 | New | $11,999,998 | $11,999,998 | Equity Only | 06b | SEC link |
| 2023-09-13 | New | $22,500,017 | $22,500,017 | Equity Only | 06b | SEC link |
| 2020-02-19 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2019-10-28 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2018-09-12 | New | $4,847,346 | $4,847,346 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Kathryn Abshire | Executive |
| Mert Aktar | Director |
| Kenji Cunnion | Executive |
| Frank Gadams | Director |
| Deborah Geraghty | Director |
| Laurie Glimcher | Director |
| John Harding | Director, Executive |
| Edward Heidt, Jr. | Director |
| Neel Krishna | Executive |
| David Marek | Director, Executive |
| Paolo Martini | Executive |
| Thomas Kerry Mc Carter | Executive |
| Andrew Miller | Director |
| Azmi Nabulsi | Director |
| Jerry Nadler | Director |
| Christine Neikirk | Director |
| Emma Reeve | Director |
| John Rickman | Executive |
| Christi Shaw | Director |
| Barry Strasnick | Director |
| Ulrich Thienel | Director, Executive |
| Lewis Williams | Director |
| Jonathan Zalevsky | Director |